Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Resolution . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1199961C enables high-selectivity splitting of DL-pantoyl internal ester for D-calcium pantothenate production reducing costs and improving supply chain reliability significantly.
Patent CN104926671A enables high-yield D-phenylalanine production with reduced costs and superior purity for pharmaceutical supply chains globally.
Novel patent CN115093392B details high-purity R-lipoic acid synthesis. Offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN112321613B reveals a novel route for high-purity Edoxaban Tosylate and isomers. Discover cost-effective manufacturing strategies for this critical anticoagulant API.
Novel synthesis route for diabetic drug intermediates via CN1434800A. Enhances purity and scalability for pharmaceutical manufacturing supply chains.
Patent CN101531647B details a safe resolution method for Ramelteon intermediates. Discover cost-effective supply chain solutions and high-purity manufacturing capabilities.
Novel method for beta-lactamase inhibitor intermediate chiral impurities. High purity ee>99.5%. Cost-effective supply chain solutions for pharma QC.
Patent CN103497145A details a scalable chemical resolution for high-purity donepezil. Discover cost-effective supply chain solutions and technical advantages.
Novel synthesis route for Alzheimer's intermediate. Eliminates column purification and chiral HPLC. Reduces cost and improves scalability for pharmaceutical manufacturing.
Patent CN105820113B reveals a novel resolution method for Crizotinib intermediates offering high purity and scalable manufacturing for global pharmaceutical supply chains.
Novel camphorsulfonic acid resolution method for high-purity 3-amino-3-phenylpropionic acid. Reduces waste and cost for Dapoxetine intermediate manufacturing.
Patent CN102093284A details a novel racemization method for piperidine-2-carboxanilide compounds, offering significant cost reduction and supply chain reliability for API manufacturing.
Advanced patent-based synthesis of Clopidogrel Bisulfate offering high yield and purity. Cost-effective pharmaceutical intermediate manufacturing for global supply chains.
Patent CN114375290A details scalable routes for Factor XIa inhibitor intermediates. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical production.
Novel chiral resolution method for S-pantoprazole sodium ensures high purity and scalable production. Ideal for pharmaceutical intermediates supply chain optimization and cost efficiency.
Patent CN107383017B reveals a novel Ibrutinib synthesis route. Discover cost reduction in API manufacturing and enhanced supply chain reliability for Btk inhibitors.
Advanced patent CN101928301B details a novel configuration inversion method for levofosfomycin production, offering significant cost reduction and high purity for pharmaceutical manufacturers.
Advanced racemization recovery for Vernakalant intermediates using phosphine reagents. Enhances yield and reduces waste for reliable pharmaceutical intermediate supply chains.
Novel 5-step route for Ozanimod intermediates reduces cost and improves safety. Ideal for API intermediates manufacturing and supply chain optimization.
Patent CN1322711A details a novel resolution method for Chloramphenicol. Discover cost-effective, high-purity pharmaceutical intermediate manufacturing solutions.